ProfileGDS5678 / 1455905_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 16% 15% 16% 15% 14% 14% 15% 16% 15% 16% 16% 40% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4138316
GSM967853U87-EV human glioblastoma xenograft - Control 22.3853516
GSM967854U87-EV human glioblastoma xenograft - Control 32.3643915
GSM967855U87-EV human glioblastoma xenograft - Control 42.3372816
GSM967856U87-EV human glioblastoma xenograft - Control 52.3326615
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.397714
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3722714
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3604715
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3595216
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.367715
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3816516
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3630216
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9257640
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3749216